Marktanalyse - Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018


Summary


GlobalData’s new report, 'Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global brachytherapy devices market. The report provides market landscape, competitive landscape and market trends information on the brachytherapy devices market, as well as comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. It also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, Australia, India, China and Brazil.
- Key categories covered include Temporary Brachytherapy Devices and Permanent Brachytherapy Devices.
- Annualized market revenues data for 2011, forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints for the brachytherapy devices market
- Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies
- Key players covered include Oncura, CR Bard, Nucletron, Theragenics, IBt Bebig and Palomar Varian Medical Systems.


Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the brachytherapy devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the brachytherapy devices market landscape? — Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global brachytherapy devices market and the factors shaping it.


Press Release:

Cancer Therapies Branch Out as Brachytherapy Gains Popularity.

While the increasing incidence of cancer is supporting the market for all cancer treatments, brachytherapy is succeeding on its own terms, as an economical, convenient and effective outpatient procedure which can provide treatment tailored to individual patient’s needs, states a new report* by healthcare experts GlobalData.

Brachytherapy is a type of radiation therapy used for the treatment of cancer, and involves placing a radioactive material inside or near the tumor. This is also known as internal radiation therapy, and allows the physician to treat a small area with a higher dose of radiation in a shorter time than for EBRT. Technological advancements such as three-dimensional (3D) treatment planning solutions allow physicians to administer incredibly accurate and precise doses, resulting in a dramatic decrease in treatment and recovery times. Permanent brachytherapy involves the insertion of radioactive pellets inside or near the tumor to then be left inside the body, while a temporary brachytherapy involves placing a highly radioactive material inside a catheter or slender tube for a specific amount of time.

The brachytherapy devices market is expected to be driven by the increasing incidence of cancer. Brachytherapy is a highly effective, outpatient procedure that is easily customizable to patients’ individual needs, and offers many benefits to the increasing numbers of patients opting for non-invasive treatment options. Brachytherapy is a high-value treatment option, which costs substantially lower than those for radical prostatectomy and Intensity-modulated Radiation Therapy (IMRT).

The positive outcome associated with temporary High Dose Rate (HDR) brachytherapy for gynecological cancers have made brachytherapy standard treatment protocol, and a similar trend of acceptance for the treatment of other types of cancer may drive future growth of the US brachytherapy devices market. Brachytherapy is currently used to treat prostate, cervix, head and neck, skin and breast cancers, but the higher adoption of brachytherapy for the treatment of cancers such as brain tumor, liver cancer and macular degeneration will continue to drive demand for brachytherapy devices in the future.

However, a more impressive track record would help to promote brachytherapy, and defend the effectiveness of the treatment against opposing evidence. A study published in the Journal of the American Medical Association claimed that older women treated with brachytherapy suffer more complications and are at a higher risk of recurrence, and are more likely to require a mastectomy later in life. Further research and more long-term studies are needed, therefore, in order to prove brachytherapy as an essential weapon against cancer.

The global brachytherapy devices market is forecast to grow from $268.2m in 2011 to $322m by 2018 at a Compound Annual Growth Rate (CAGR) of 3%.

*Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

This report provides key data, information and analysis on the global brachytherapy devices market. The report provides market landscape, competitive landscape and market trends information on the market, as well as comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. It also reviews the competitive landscape and technology offerings.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 GlobalData Report Guidance 7

3 Disease Overview 8

3.1 Breast Cancer 8

3.2 Signs and Symptoms 8

3.3 Epidemiology 8

3.4 Prostate Cancer 10

3.5 Signs and Symptoms 10

3.6 Epidemiology 11

4 Brachytherapy - Device Overview 13

4.1 Brachytherapy, Market Segmentation 14

4.1.1 Temporary Brachytherapy 14

4.1.2 Permanent Brachytherapy 15

5 Brachytherapy Devices - Global Market Characterization 16

5.1 Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2004—2011 16

5.2 Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 2011—2018 17

5.3 Brachytherapy Devices Market, Key Trends 18

5.3.1 Multiple Imaging Techniques and High-precision Targeted Brachytherapy Play a Major Role in Deciding Brachytherapy Treatment Planning 18

5.3.2 New Radioisotopes for Increased Effectiveness Constantly Explored for Delivering Brachytherapy 19

5.4 Brachytherapy Devices, Market Dynamics 20

5.4.1 Market Drivers 21

5.4.2 Market Restraints 25

6 Brachytherapy Devices Market, Global, Segment Analysis, Revenue ($m), 2004—2018 27

6.1 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2004—2011 27

6.2 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 2011—2018 28

6.3 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2004—2011 29

6.4 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 2011—2018 30

7 Brachytherapy Devices Market, by Country, Revenue ($m), 2004—2018 31

7.1 Brachytherapy Devices Market, The US, Revenue ($m), Historic, 2004—2011 31

7.2 Brachytherapy Devices Market, The US, Revenue ($m), Forecast, 2011—2018 32

7.3 Brachytherapy Devices Market, The UK, Revenue ($m), Historic, 2004—2011 33

7.4 Brachytherapy Devices Market, The UK, Revenue ($m), Forecast, 2011—2018 34

7.5 Brachytherapy Devices Market, Germany, Revenue ($m), Historic, 2004—2011 35

7.6 Brachytherapy Devices Market, Germany, Revenue ($m), Forecast, 2011—2018 36

7.7 Brachytherapy Devices Market, France, Revenue ($m), Historic, 2004—2011 37

7.8 Brachytherapy Devices Market, France, Revenue ($m), Forecast, 2011—2018 38

7.9 Brachytherapy Devices Market, Italy, Revenue ($m), Historic, 2004—2011 39

7.10 Brachytherapy Devices Market, Italy, Revenue ($m), Forecast, 2011—2018 40

7.11 Brachytherapy Devices Market, Spain, Revenue ($m), Historic, 2004—2011 41

7.12 Brachytherapy Devices Market, Spain, Revenue ($m), Forecast, 2011—2018 42

7.13 Brachytherapy Devices Market, Japan, Revenue ($m), Historic, 2004—2011 43

7.14 Brachytherapy Devices Market, Japan, Revenue ($m), Forecast, 2011—2018 44

8 Brachytherapy Devices Market: Company Shares (%), 2011 45

8.1 Brachytherapy Devices Market, Global, Company Share (%), 2011 45

8.2 Temporary Brachytherapy Devices Market, Global, Company Share (%), 2011 47

8.3 Permanent Brachytherapy Devices Market, Global, Company Share (%), 2011 48

8.4 Brachytherapy Devices Market, Global, Competitive Assessment, 2011 50

8.5 Brachytherapy Devices Market, Key Market Participants 51

8.5.1 Oncura 51

8.5.2 C.R. Bard 53

8.5.3 Nucletron (an Elekta Company) 55

8.5.4 Theragenics 58

8.5.5 IBt Bebig 60

8.5.6 Varian Medical Systems, Inc. 62

9 Brachytherapy Devices Market, Deals Landscape 66

9.1 Brachytherapy Devices Market, Key Acquisitions, 2008—2012 67

9.1.1 Elekta Completes Acquisition of Nucletron for $523m 67

9.1.2 Eckert & Ziegler Subsidiary IBt Bebig Acquires SonoTECH GmbH 67

9.1.3 C. R. Bard Completes Acquisition of SenoRx for $213m 68

9.1.4 Huiheng Medical Completes Acquisition of Portola Medical 68

9.1.5 iCAD Completes Acquisition of Xoft 68

9.2 Brachytherapy Devices Market: Partnerships 69

9.3 Brachytherapy Devices Market: Key Partnerships, 2008—2012 70

9.3.1 Integrated Oncology Network Announced Partnership and has Acquired Equity Interests in Prologics and Northern Ohio Regional Cancer Center 70

9.3.2 IBA Dosimetry Enters into Distribution Agreement with Axios Oncology 71

9.3.3 Theragenics Signs Distribution Agreement with Oncura 71

9.3.4 Nucletron Enters into Licensing Agreement with MedCom and Pi-Medical 71

9.3.5 IsoRay Enters into Exclusive Licensing Agreement with Hologic 71

9.3.6 Theragenics Signs an Agreement with Core Oncology 72

10 Appendix 73

10.1 Market Definitions 73

10.1.1 Brachytherapy Devices 73

10.1.2 Permanent Brachytherapy Devices 73

10.1.3 Temporary Brachytherapy Devices 74

10.2 Acronyms 74

10.3 Sources 76

10.4 Research Methodology 77

10.4.1 Secondary Research 77

10.4.2 Primary Research 77

10.4.3 Models 78

10.4.4 Forecasts 78

10.4.5 Expert Panels 78

10.4.6 GlobalData Consulting 78

10.5 Contact Us 79

10.6 Disclaimer 79





1.1 List of Tables

Table 1: Breast Cancer, Disease Population by Country, 2006-2011 9

Table 2: Prostate Cancer, Disease Population by Country, 2006-2011 11

Table 3: Brachytherapy Classification, 2012 14

Table 4: Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 16

Table 5: Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 17

Table 6: Physical Properties of New Brachytherapy Sources under Investigation 19

Table 7: Estimated Number of New Cancer Patients per 100,000 Population (All Ages), 2008-2020 21

Table 8: Cumulative Mean Prostate Cancer Treatment Costs over Five and Half Years, by Primary Treatment and Risk Factor 22

Table 9: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 27

Table 10: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 28

Table 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 29

Table 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 30

Table 13: Brachytherapy Devices Market, The US, Revenue ($m), 2004-2011 31

Table 14: Brachytherapy Devices Market, The US, Revenue ($m), 2011-2018 32

Table 15: Brachytherapy Devices Market, The UK, Revenue ($m), 2004-2011 33

Table 16: Brachytherapy Devices Market, The UK, Revenue ($m), 2011-2018 34

Table 17: Brachytherapy Devices Market, Germany, Revenue ($m), 2004-2011 35

Table 18: Brachytherapy Devices Market, Germany, Revenue ($m), 2011-2018 36

Table 19: Brachytherapy Devices Market, France, Revenue ($m), 2004-2011 37

Table 20: Brachytherapy Devices Market, France, Revenue ($m), 2011-2018 38

Table 21: Brachytherapy Devices Market, Italy, Revenue ($m), 2004-2011 39

Table 22: Brachytherapy Devices Market, Italy, Revenue ($m), 2011-2018 40

Table 23: Brachytherapy Devices Market, Spain, Revenue ($m), 2004-2011 41

Table 24: Brachytherapy Devices Market, Spain, Revenue ($m), 2011-2018 42

Table 25: Brachytherapy Devices Market, Japan, Revenue ($m), 2004-2011 43

Table 26: Brachytherapy Devices Market, Japan, Revenue ($m), 2011-2018 44

Table 27: Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 45

Table 28: Temporary Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 47

Table 29: Permanent Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 48

Table 30: Oncura, Key Marketed Products, 2011 51

Table 31: C. R. Bard Inc., Key Marketed Products, 2011 53

Table 32: Nucletron, Brachytherapy, Key Marketed Products, 2011 56

Table 33: Theragenics Corporation, Brachytherapy, Key Marketed Products, 2011 58

Table 34: IBt Bebig, Key Marketed Products, 2011 60

Table 35: Varian Medical Systems, Inc, Key Marketed Products, 2011 62

Table 36: Brachytherapy Devices Market, Mergers and Acquisitions, Global, 2008-2012* 66

Table 37: Brachytherapy Devices Market, Partnerships, Global, 2008-2012* 69





1.2 List of Figures

Figure 1: Breast Cancer, Disease Population by Country, 2006—2011 9

Figure 2: Prostate Cancer, Disease Population by Country, 2006—2011 11

Figure 3: Brachytherapy Devices Market, Segmentation, 2012 14

Figure 4: Brachytherapy Devices Market, Global, Revenue ($m), 2004—2011 16

Figure 5: Brachytherapy Devices Market, Global, Revenue ($m), 2011—2018 17

Figure 6: Brachytherapy Devices, Market Dynamics 20

Figure 7: Estimated Number of New Cancer Patients per 100,000 Population (All Ages), 2008—2020 21

Figure 8: Use of Brachytherapy in Cancer Treatment, 2010 23

Figure 9: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2004—2011 27

Figure 10: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2011—2018 28

Figure 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2004—2011 29

Figure 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2011—2018 30

Figure 13: Brachytherapy Devices Market, The US, Revenue ($m), 2004—2011 31

Figure 14: Brachytherapy Devices Market, The US, Revenue ($m), 2011—2018 32

Figure 15: Brachytherapy Devices Market, The UK, Revenue ($m), 2004—2011 33

Figure 16: Brachytherapy Devices Market, The UK, Revenue ($m), 2011—2018 34

Figure 17: Brachytherapy Devices Market, Germany, Revenue ($m), 2004—2011 35

Figure 18: Brachytherapy Devices Market, Germany, Revenue ($m), 2011—2018 36

Figure 19: Brachytherapy Devices Market, France, Revenue ($m), 2004—2011 37

Figure 20: Brachytherapy Devices Market, France, Revenue ($m), 2011—2018 38

Figure 21: Brachytherapy Devices Market, Italy, Revenue ($m), 2004—2011 39

Figure 22: Brachytherapy Devices Market, Italy, Revenue ($m), 2011—2018 40

Figure 23: Brachytherapy Devices Market, Spain, Revenue ($m), 2004—2011 41

Figure 24: Brachytherapy Devices Market, Spain, Revenue ($m), 2011—2018 42

Figure 25: Brachytherapy Devices Market, Japan, Revenue ($m), 2004—2011 43

Figure 26: Brachytherapy Devices Market, Japan, Revenue ($m), 2011—2018 44

Figure 27: Brachytherapy Devices Market, Global, Company Share (%), 2011 45

Figure 28: Temporary Brachytherapy Devices Market, Global, Company Share (%), 2011 47

Figure 29: Permanent Brachytherapy Devices Market, Global, Company Share (%), 2011 48

Figure 30: Brachytherapy Devices Market, Global, Competitive Assessment, 2011 50

Figure 31: Oncura, SWOT Analysis, 2012 51

Figure 32: C.R. Bard, SWOT Analysis, 2012 54

Figure 33: Nucletron, SWOT Analysis, 2012 56

Figure 34: Nucletron, Product Launches, 2007-2012 57

Figure 35: Theragenics, SWOT Analysis, 2012 59

Figure 36: IBt Bebig, SWOT Analysis, 2012 61

Figure 37: Varian Medical Systems, Inc, SWOT Analysis, 2012 63

Figure 38: Varian, Product Launches, 2007-2012 64

• Global Medical Dressing Market
• Global Medication Management System Market 2012-2016
• ICT Spend Predictions in Large Brazilian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Canadian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large French Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large German Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Mexican Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large Spanish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large UK Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Large US Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized Brazilian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized Canadian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized French Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized German Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized Mexican Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized Spanish Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized UK Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Medium-sized US Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Small Brazilian Healthcare Providers - Estimated ICT budget breakdowns in 2013
• ICT Spend Predictions in Small Canadian Healthcare Providers - Estimated ICT budget breakdowns in 2013